title: Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation.
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.forename: S
authors.initials: S
authors.lastname: Guidi
authors.forename: P
authors.initials: P
authors.lastname: Guglielmelli
authors.forename: S
authors.initials: S
authors.lastname: Glinz
authors.forename: L
authors.initials: L
authors.lastname: Lombardini
authors.forename: A
authors.initials: A
authors.lastname: Busca
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
authors.forename: A M
authors.initials: AM
authors.lastname: Dall'Omo
authors.forename: A
authors.initials: A
authors.lastname: Bosi
mesh_terms: D015703:Antigens, CD / Q000235:genetics*; D000943:Antigens, Differentiation / Q000235:genetics*; D060908:CTLA-4 Antigen; D006086:Graft vs Host Disease / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000235:genetics*; D011110:Polymorphism, Genetic; D023001:Transplantation Tolerance; D016896:Treatment Outcome
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018950:Lipopolysaccharide Receptors